Abstract
Understanding the conditionally-dependent clinical variables that drive cardiovascular health outcomes is a major challenge for precision medicine. Here, we deploy a recently developed massively scalable comorbidity discovery method called Poisson Binomial based Comorbidity discovery (PBC), to analyze Electronic Health Records (EHRs) from the University of Utah and Primary Children’s Hospital (over 1.6 million patients and 77 million visits) for comorbid diagnoses, procedures, and medications. Using explainable Artificial Intelligence (AI) methodologies, we then tease apart the intertwined, conditionally-dependent impacts of comorbid conditions and demography upon cardiovascular health, focusing on the key areas of heart transplant, sinoatrial node dysfunction and various forms of congenital heart disease. The resulting multimorbidity networks make possible wide-ranging explorations of the comorbid and demographic landscapes surrounding these cardiovascular outcomes, and can be distributed as web-based tools for further community-based outcomes research. The ability to transform enormous collections of EHRs into compact, portable tools devoid of Protected Health Information solves many of the legal, technological, and data-scientific challenges associated with large-scale EHR analyzes.
Competing Interest Statement
GL, VD, MY own shares in Backdrop Health, there are no financial ties regarding this research.
Funding Statement
We thank Barry Moore, Jacob Shreiber, Jerry Rudisin, Sepideh Ebadi, Edward B. Clark and members of the University of Utah EDW, UPDB and Utah Center for High Performance Computing for insightful discussions, facilitating access to medical records and familial relationships, and computational support. This research was supported by the AHA Children's Strategically Focused Research Network grant (17SFRN33630041) and the Nora Eccles Treadwell Foundation. Rebecca Delaney's effort was supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award T32 HL007576 from the National Heart, Lung, and Blood Institute. Gordon Lemmon was supported by NRSA training grant T32H757632. Sergiusz Wesolowski was supported by NRSA training grant T32DK110966-04.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Human subjects approval for this study was obtained following review by the University of Utah Institutional Review Board, IRB_00095807. All authors completed Human Subjects research requirements.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* equal contribution
Data Availability
All Probabilistic Graphical Models described in this paper are available through the web using the following link: https://pbc.genetics.utah.edu/lemmon2021/bayes/bayes.